Orion Pharma Limited (DSE:ORIONPHARM)

United States Steel Revenue

Orion Pharma had revenue of 845.07M BDT in the quarter ending March 31, 2025, a decrease of -58.48%. This brings the company's revenue in the last twelve months to 6.19B, down -46.14% year-over-year. In the fiscal year ending June 30, 2024, Orion Pharma had annual revenue of 10.62B, down -23.74%.

• Revenue (ttm): 6.19B
• Revenue Growth: -46.14%
• P/S Ratio: 1.20
• Revenue / Employee: 1.96M
• Employees: 3,160
• Market Cap: 7.44B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	10.62B	-3.31B	-23.74%
Jun 30, 2023	13.93B	4.26B	44.14%
Jun 30, 2022	9.66B	-1.17B	-10.81%
Jun 30, 2021	10.83B	3.18B	41.64%
Jun 30, 2020	7.65B	-1.06B	-12.15%